BCG Vaccines Sales Market Dynamics and Developments by 2031

Coverage: by Type (Immune BCG and Therapy BCG); Application (Clinics, Hospitals and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031
  • Status : Data Released
  • Report Code : TIPRE00004432
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : January 27, 2025
BCG Vaccines Sales Market Dynamics and Developments by 2031
Report Date: January 27, 2025   |   Report Code: TIPRE00004432 Email: sales@theinsightpartners.com
Buy Now

2024 Market Size

US$ 104.11 Mn

Base year value

2031 Forecast

US$ 148.46 Mn

Projected by 2031

CAGR 2025-2031

5.2 %

Growth rate

Addressable Market

US$ 897.19 Mn

(2025-2031)

The Bcg Vaccines Sales Market size is expected to reach US$ 148.46 Million by 2031. The market is anticipated to register a CAGR of 5.2% during 2025-2031.

The BCG Vaccines Sales Market report covers analysis by Type (Immune BCG and Therapy BCG); Application (Clinics, Hospitals and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report BCG Vaccines Sales Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

BCG Vaccines Sales Market Segmentation Type

  1. Immune BCG and Therapy BCG

Application

  1. Clinics
  2. Hospitals and Others

Market Assessment and Insights

  • Global market for BCG Vaccines Sales was valued at US$ 104.11 Million in 2024
  • Annual market size is expected to reach US$ 148.46 Million by 2031
  • Total addressable market (TAM) during 2025-2031 is projected to reach approximately US$ 897.19 Million
  • Market is anticipated to register a CAGR of 5.2% during the forecast period
  • The United States represents a key market, supported by Global Prevalence of Tuberculosis (TB), Government Initiatives and Immunization Programs, Rising Awareness of TB Prevention, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Potential for Therapeutic Uses, Public-Private Partnerships (PPPs), Vaccine Supply Chain Improvements are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including AJ Vaccines, China National Pharmaceutical Group Corporation, GreenSignal Bio Pharma Private Limited, Intervax Ltd, Japan BCG Laboratory, Merck Sharp & Dohme Corp, Sanofi S. A., Serum Institute of India Pvt Ltd, Statens Serum Institute, Shanghai Institute of Biological Products, while analyzing competitive strategies and innovation developments

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

BCG Vaccines Sales Market: Strategic Insights

bcg-vaccines-sales-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

BCG Vaccines Sales Market Growth Drivers

  1. Global Prevalence of Tuberculosis (TB):
    Tuberculosis remains a major health threat, especially in developing countries, which increases the demand for BCG vaccines as the primary preventive measure against TB.
  2. Government Initiatives and Immunization Programs:
    Many governments and international health organizations, such as the World Health Organization (WHO), promote vaccination programs to control TB, boosting the demand for BCG vaccines globally.
  3. Rising Awareness of TB Prevention:
    Increased awareness and global efforts to reduce TB transmission are leading to higher vaccination rates and demand for BCG vaccines, especially in high-risk regions.

BCG Vaccines Sales Market Future Trends

  1. Introduction of Combined Vaccines:
    Researchers and manufacturers are developing combination vaccines that include BCG alongside other vaccines to streamline immunization schedules, potentially increasing demand for BCG as part of multi-vaccine options.
  2. Focus on Pediatric Vaccination:
    BCG vaccination is primarily administered to infants to prevent severe forms of TB. This focus on pediatric vaccination continues to be a significant driver of BCG vaccine sales globally.
  3. Research on New Applications:
    BCG vaccines are also being explored for their potential use in treating other diseases, such as bladder cancer, and for boosting immunity against COVID-19. This research could open new markets and boost sales.

BCG Vaccines Sales Market Opportunities

  1. Potential for Therapeutic Uses:
    Beyond TB, ongoing research into the potential therapeutic uses of BCG vaccines, such as their role in treating cancer, particularly bladder cancer, could create new revenue streams for the market.
  2. Public-Private Partnerships (PPPs):
    Collaborations between governments, international organizations, and private companies can help increase vaccine availability and distribution, especially in regions with high TB prevalence, offering opportunities for market expansion.
  3. Vaccine Supply Chain Improvements:
    Advancements in global vaccine distribution networks, including cold chain logistics and affordable pricing strategies, provide an opportunity to reach more populations in need, particularly in rural or remote areas.

BCG Vaccines Sales Market Report Scope

Report Attribute Details
Market size in 2024 US$ 104.11 Million
Market Size by 2031 US$ 148.46 Million
Global CAGR (2025 - 2031) 5.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Immune BCG and Therapy BCG
By Application
  • Clinics
  • Hospitals and Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AJ Vaccines
  • China National Pharmaceutical Group Corporation
  • GreenSignal Bio Pharma Private Limited
  • Intervax Ltd
  • Japan BCG Laboratory
  • Merck Sharp & Dohme Corp
  • Sanofi S. A.
  • Serum Institute of India Pvt Ltd
  • Statens Serum Institute
  • Shanghai Institute of Biological Products

BCG Vaccines Sales Market Players Density: Understanding Its Impact on Business Dynamics

The BCG Vaccines Sales Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

bcg-vaccines-sales-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the BCG Vaccines Sales Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the BCG Vaccines Sales Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

Key companies of this market are: AJ Vaccines, China National Pharmaceutical Group Corporation, GreenSignal Bio Pharma Private Limited, Intervax Ltd, Japan BCG Laboratory, Merck Sharp & Dohme Corp, Sanofi S.A., Serum Institute of India Pvt Ltd, Statens Serum Institute, Shanghai Institute of Biological Products.

Key future trends in this market are - Tuberculosis Control Programs, Non-Tuberculosis Applications, Supply Chain Optimization

The BCG Vaccines Sales Market is estimated to witness a CAGR of 5.2% from 2025 to 2031.

The major factors driving the market are: Increased tuberculosis prevalence, Rising awareness and government support, Emerging applications in cancer therapy
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA